Why the study?
Do clinical risk factors and lower body weight increase the risk of major bleeding in adults receiving alteplase for pulmonary embolism?
Do clinical risk factors and lower body weight increase the risk of major bleeding in adults receiving alteplase for pulmonary embolism?
The presence of one or more clinical risk factors for bleeding and lower body weight are independently associated with a significantly higher risk of major bleeding in patients receiving alteplase for pulmonary embolism.
Alerts to higher major bleeding risk with bleeding factors or lower weight in alteplase-treated PE; leaves open prospective validation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Curtis et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: